Viewing StudyNCT00499109



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00499109
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2007-07-10

Brief Title: Phase III of RRM1 ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Organization Data

Organization: H Lee Moffitt Cancer Center and Research Institute
Class: OTHER
Study ID: MCC-15005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Sanofi INDUSTRY